The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Ethyl-5-(p-tolyl)-5,7,8,9-tetrahydro-1H-cyclopenta[5,6]pyrido-[2,3-d]pyrimidine-2,4,6(3H)-trione ID: ALA4093510
PubChem CID: 137654718
Max Phase: Preclinical
Molecular Formula: C19H19N3O3
Molecular Weight: 337.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCn1c2c(c(=O)[nH]c1=O)C(c1ccc(C)cc1)C1=C(CCC1=O)N2
Standard InChI: InChI=1S/C19H19N3O3/c1-3-22-17-16(18(24)21-19(22)25)14(11-6-4-10(2)5-7-11)15-12(20-17)8-9-13(15)23/h4-7,14,20H,3,8-9H2,1-2H3,(H,21,24,25)
Standard InChI Key: GFYQCHZFSLHBOA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
14.0478 -12.7498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3402 -13.1537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6338 -12.7446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6350 -11.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3468 -11.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0532 -11.9326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9287 -11.5142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2210 -11.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2156 -12.7394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9220 -13.1485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4409 -12.9849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9610 -12.3226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4455 -11.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7542 -13.1589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3480 -10.7022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1959 -10.8836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9340 -10.6970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2276 -10.2879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9406 -9.0626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6458 -10.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2330 -9.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6470 -9.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9460 -8.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3348 -13.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0412 -14.3841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 12 1 0
12 13 1 0
8 13 1 0
9 11 1 0
3 10 1 0
4 7 1 0
1 14 2 0
5 15 2 0
13 16 2 0
17 18 1 0
17 20 2 0
18 21 2 0
19 21 1 0
19 22 2 0
20 22 1 0
19 23 1 0
7 17 1 0
24 25 1 0
2 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.38Molecular Weight (Monoisotopic): 337.1426AlogP: 2.04#Rotatable Bonds: 2Polar Surface Area: 83.96Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.88CX Basic pKa: ┄CX LogP: 1.68CX LogD: 1.68Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.88Np Likeness Score: -0.95
References 1. Ayoub AM, Hawk LML, Herzig RJ, Jiang J, Wisniewski AJ, Gee CT, Zhao P, Zhu JY, Berndt N, Offei-Addo NK, Scott TG, Qi J, Bradner JE, Ward TR, Schönbrunn E, Georg GI, Pomerantz WCK.. (2017) BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen., 60 (12): [PMID:28535045 ] [10.1021/acs.jmedchem.6b01336 ]